Ono Richard Dana
Insider CIK 1595989 · HPPI Director · LPCN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LPCN Lipocine Inc. | A Award deriv | 2026-06-03 | 2026-06-04 | 1,764 | $2.19 | $3.9K | 13,290 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2025-06-04 | 2025-06-05 | 1,764 | $3.20 | $5.6K | 11,526 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 1,764 | $7.05 | $12.4K | 10,938 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2023-05-10 | 2023-05-12 | 30,000 | $0.27 | $8.1K | 166,000 | SEC↗ |
| LPCN Lipocine Inc. | P Buy | 2023-03-20 | 2023-03-20 | 4,000 | $0.34 | $1.4K | 14,125 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 22,000 | $0.92 | $20.2K | 136,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2021-06-09 | 2021-06-10 | 22,000 | $1.26 | $27.7K | 22,000 | SEC↗ |
| INTI Inhibitor Therapeutics, In | A Award deriv | 2020-12-22 | 2020-12-28 | 754,839 | — | $0 | 754,839 | SEC↗ |
| LPCN Lipocine Inc. | M Exercise deriv | 2020-12-16 | 2020-12-17 | 5,250 | — | $0 | 5,250 | SEC↗ |
| LPCN Lipocine Inc. | M Exercise | 2020-12-16 | 2020-12-17 | 5,250 | — | $0 | 10,125 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2020-06-10 | 2020-06-10 | 22,000 | $0.96 | $21.1K | 22,000 | SEC↗ |
| INTI Inhibitor Therapeutics, In | A Award deriv | 2020-03-20 | 2020-03-24 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 10,000 | $1.68 | $16.8K | 10,000 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | A Award deriv | 2019-02-03 | 2019-02-05 | 657,895 | — | $0 | 657,895 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2018-06-27 | 2018-06-28 | 20,000 | $1.33 | $26.6K | 20,000 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | A Award deriv | 2018-03-13 | 2018-03-15 | 56,000 | — | $0 | 56,000 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | A Award deriv | 2018-03-13 | 2018-03-15 | 253,000 | — | $0 | 253,000 | SEC↗ |
| LPCN Lipocine Inc. | M Exercise deriv | 2017-12-29 | 2018-01-02 | 1,750 | — | $0 | 5,250 | SEC↗ |
| LPCN Lipocine Inc. | S Sale | 2017-12-29 | 2018-01-02 | 875 | $3.47 | $3.0K | 4,875 | SEC↗ |
| LPCN Lipocine Inc. | M Exercise | 2017-12-29 | 2018-01-02 | 1,750 | — | $0 | 5,750 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | M Exercise deriv | 2017-03-08 | 2017-03-10 | 300,000 | — | $0 | 0 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | M Exercise deriv | 2017-03-08 | 2017-03-10 | 150,000 | — | $0 | 0 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | M Exercise deriv | 2017-03-08 | 2017-03-10 | 300,000 | — | $0 | 0 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | M Exercise | 2017-03-08 | 2017-03-10 | 300,000 | — | $0 | 300,000 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | F Tax w/h | 2017-03-08 | 2017-03-10 | 118,800 | $0.34 | $40.4K | 181,200 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | F Tax w/h | 2017-03-08 | 2017-03-10 | 118,800 | $0.34 | $40.4K | 362,400 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | M Exercise | 2017-03-08 | 2017-03-10 | 300,000 | — | $0 | 481,200 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | M Exercise | 2017-03-08 | 2017-03-10 | 150,000 | — | $0 | 512,400 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | F Tax w/h | 2017-03-08 | 2017-03-10 | 59,400 | $0.34 | $20.2K | 453,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2017-01-26 | 2017-01-30 | 7,000 | — | $0 | 7,000 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | A Award deriv | 2016-07-01 | 2016-07-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | A Award deriv | 2016-07-01 | 2016-07-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2016-06-14 | 2016-06-17 | 10,000 | $8.02 | $80.2K | 10,000 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | A Award deriv | 2015-08-14 | 2015-08-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2015-06-16 | 2015-06-17 | 20,000 | — | $0 | 30,000 | SEC↗ |
| LPCN Lipocine Inc. | P Buy | 2014-11-19 | 2014-11-19 | 4,000 | $5.14 | $20.6K | 4,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2014-01-06 | 2014-01-08 | 10,000 | — | $0 | 10,000 | SEC↗ |